Venrock | Activity | F4

Team Portfolio Raise Essays

F4/Venrock/Activity

Venrock Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Milestone

Suki, the leader in Ambient Clinical Intelligence, raised $90M in Series E financing. Venrock participated as an existing institutional investor. Suki now serves 450+ healthcare organizations.

Suki

suki.aiOCT 13, 2026

OCT 13, 2026

Investment

Led the $15.5M seed round for Arca Wealth, an AI-powered wealth management platform.

Arca

fintechfutures.comJUN 25, 2026

JUN 25, 2026

Exit

Portfolio company Apogee Therapeutics acquired by AbbVie for $10.9B, deepening AbbVie's immunology portfolio.

Apogee Therapeutics

Apogee Therapeutics Venrock

news.abbvie.comJUN 22, 2026

JUN 22, 2026

Exit

Eli Lilly acquired Kelonia Therapeutics for up to $7B. Venrock, an early investor, is reported to see a 45-70x return on its investment.

Kelonia Therapeutics

Kelonia TherapeuticsVenrock

reuters.comAPR 20, 2026

APR 20, 2026

Team Change

Promoted Mariana Mihalusova and Phil DiGiacomo to partner.

Mariana Mihalusova and Phil DiGiacomo

venrock.comAPR 13, 2026

APR 13, 2026

Essay

Published essay on 2026 biotech market trends and challenges.

Biotech in 2026: Changing Tide, but Treacherous Currents

venrock.comMAR 2026

MAR 2026

Investment

Led Korro Bio's $85M private placement financing.

Korro Bio

Korro Bio Venrock

ir.korrobio.comMAR 2026

ir.korrobio.com

MAR 2026

Essay

Released 'Beyond the Battlefield' report on defense industry insights.

Beyond the Battlefield 2026

venrock.comFEB 2026

FEB 2026

Investment

Co-led GenLogs' $60M Series B for supply chain intelligence platform.

GenLogs

GenLogs Venrock

venrock.comFEB 2026

FEB 2026

Investment

Venrock (Nick Beim) led FINNY's $17M Series A at a $150M valuation. FINNY uses AI for automated organic growth for RIAs, serving 400 firms with 50X revenue growth since January 2025.

FINNY

riabiz.comDEC 24, 2025

DEC 24, 2025